We are live on
!
Find out more
HCM
Harvey Capital Management Portfolio holdings
AUM
$439M
1-Year Est. Return
37.68%
This Fund
S&P 500
This Quarter
Est. Return
+11.9%
1 Year Est. Return
+37.68%
3 Year Est. Return
+140.63%
5 Year Est. Return
+188.51%
10 Year Est. Return
+681.53%
AUM
$225M
AUM Growth
+$24M
(+12%)
Cap. Flow
+$4.25M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
46.71%
Holding
81
New
7
Increased
13
Reduced
19
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.53M |
| 2 |
Oracle
ORCL
|
+$3.34M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$2.97M |
| 4 |
PayPal
PYPL
|
+$2.14M |
| 5 |
Adobe
ADBE
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.12M |
| 2 |
Nutrien
NTR
|
+$4.95M |
| 3 |
Diamondback Energy
FANG
|
+$2.33M |
| 4 |
Caterpillar
CAT
|
+$2.27M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 23.48% |
| 2 | Consumer Discretionary | 19.93% |
| 3 | Technology | 14.85% |
| 4 | Financials | 12.02% |
| 5 | Healthcare | 11.69% |
Similar funds
STCG
CDMG
WAS
DCM
DA
CCT
SCP
CAAM
Harvey Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Harvey Capital Management held 81 positions worth $225M, up 12% from $201M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Harvey Capital Management's Q4 2019 filing shows 7 new, 13 increased, 19 reduced and 4 closed positions. Its largest new stake was PayPal: 20,515 shares worth $2.22M. The largest sale was Celgene Corp, an estimated $6.12M.
By sector, the portfolio is most concentrated in Communication Services at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
- Harvey Capital Management's largest Q4 2019 buy was PayPal: 20,515 shares worth $2.22M.
- Harvey Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.53M increase.
- Harvey Capital Management's biggest Q4 2019 reduction was Diamondback Energy, cutting an estimated $2.33M.
- Harvey Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.12M.
- Harvey Capital Management's ten largest holdings make up 47% of its $225M portfolio in Q4 2019.
- Harvey Capital Management opened 7 new positions and closed 4 in Q4 2019.
- Harvey Capital Management's portfolio value rose 12% quarter-over-quarter to $225M.
Based on Harvey Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.